Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Chiron

Division of Novartis AG
www.chiron.com

Latest From Chiron

Astellas Strengthens Next-Gen I-O Hand With $665m Xyphos Buy

Astellas pays to play in next-generation immuno-oncology through deal for young, privately held US venture and its novel modulation platform.

M & A ImmunoOncology

Jallal To Lead Immunocore, Building On Partnership She Forged At MedImmune

A key figure in AstraZeneca’s resurgence, Jallal now leaves to head up a clinical-stage firm. She’s been an outspoken advocate for greater gender equity in biopharma leadership.

Leadership Commercial

US FDA Touts Value Of Phase III Trials Amid Presidential Transition

As future of agency remains uncertain, report makes the case for strict approval standards.

Drug Approval Standards Research & Development

Venture Funding Deals, January 2016

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a comprehensive monthly review of emerging life science companies that have received venture funding, including companies within the In Vitro Diagnostics, Medical Devices, and Pharmaceuticals sectors. This month’s column covers deals announced November through December 2015.

BioPharmaceutical Medical Device
See All

Company Information

UsernamePublicRestriction

Register